A former officer systematically liquidating over 95K shares in three months, including after a stock option exercise, signals minimal insider conviction in the near-term outlook. The Form 144's failure to list any open-market purchases in the 'securities sold in past 3 months' column reinforces the one-way selling. Traders should watch for further 144 filings and consider the possibility Bartram may be fully exiting his position.
Price Chart
Executive Summary
Richard Bartram, a former officer of MBX Biosciences, filed a Form 144 notice of intent to sell 10,833 shares of common stock with an estimated market value of approximately $321,273. This follows a series of 8 prior sales by the same insider over the past three months totaling ~$3.2M in proceeds, suggesting a systematic exit pattern.
Key Facts
- Richard Bartram, a former officer of MBX Biosciences, filed a Form 144 on June 9, 2026 to sell 10,833 shares.
- Estimated market value of the proposed sale: $321,273.40.
- Bartram has executed 8 prior open-market sales from March 16 through May 13, 2026, totaling 84,984 shares worth approximately $3.18 million.
- No other insider transactions appear in the 30-day market data snapshot, making this a solo selling pattern.
- The sales follow a stock option exercise (same date), converting equity awards to cash.
- Company market cap is $1.4B with 88% analyst bullish consensus, but the stock has declined significantly in recent weeks.
Financial Impact
Proposed sale of $321K (0.02% of market cap). Combined with prior 84.9K shares sold (~$3.18M) over 3 months, total insider selling reaches ~$3.5M, representing approximately 0.25% of market cap.
Risk Factors
- Former officer's persistent selling may foretell poor upcoming clinical or financial results.
- Single insider selling does not guarantee a decline, but this is a systematic liquidation sequence, not a one-off tax-planning sale.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004487 |
| Document: 0001959173-26-004487-index.html | 0001959173-26-004487 |
| Document: 0001959173-26-004487.txt | 0001959173-26-004487 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 3 | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $50.29 (−0.34%) |
Oct 22, 2026 4d ago | 8-K | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $50.29 (−0.34%) |
Aug 27, 2026 8w ago | Press Release | $66.39 $63.00 | ▼ −5.11% | ▼ −4.88% | $50.29 (−24.25%) |
Aug 17, 2026 10w ago | 144 | $68.25 $66.52 | ▼ −2.53% | ▼ −1.86% | $50.29 (−26.32%) |
Aug 6, 2026 11w ago | 8-K | $67.11 $67.82 | ▲ +1.06% | ▲ +0.45% | $50.29 (−25.06%) |
Jun 12, 2026 19w ago | 8-K | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $50.29 (+41.62%) |
Jun 12, 2026 19w ago | Press Release | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $50.29 (+41.62%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $50.29 (+35.01%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $50.29 (+35.01%) |
Jun 10, 2026 19w ago | 144 | $30.99 $37.25 | ▲ +20.20% | ▲ +18.50% | $50.29 (+62.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers